| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Common Stock | Options Exercise | $0 | +22,161 | +18% | $0.000000 | 147,504 | 04 May 2024 | Direct | |
| transaction | OGN | Common Stock | Tax liability | $240,340 | -12,256 | -8.3% | $19.61 | 135,248 | 04 May 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -22,161 | -100% | $0.000000* | 0 | 04 May 2024 | Common Stock | 22,161 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. |
| F2 | On each of May 4, 2022, May 4, 2023 and May 4, 2024, one-third of the RSUs vested. |